[1] |
Meraldi P, Honda R, Nigg EA. Aurora kinases Link chromosome segregation and cell division to cancer susceptibility[J]. Curr Opin Genet Dev, 2004, 14(1): 29-36.
|
[2] |
Giet R, Prigent C. Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases[J]. J Cell Sci, 1999, 112(Pt 21): 3591-3601.
|
[3] |
Kaestner P, Stolz A, Bastians H. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells[J]. Mol Cancer Ther, 2009, 8(7): 2046-2056.
|
[4] |
Vankayalapati H, Bearss DJ, Saldanha JW, et al. Targeting Aurora2 kinase in oncogenesis: a structural bioinformatics approach to target validation and rational drug design[J]. Mol Cancer Ther, 2003, 2(3): 283-294.
|
[5] |
Marumoto T, Zhang D, Saya H. Aurora-A - a Guardian of poles[J]. Nat Rev Cancer, 2005, 5(1): 42-50.
|
[6] |
Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents[J]. Nat Rev Cancer, 2004, 4(12): 927-936.
|
[7] |
Dar AA, Goff LW, Majid S, et al.Aurora kinase inhibitors--rising stars in cancer therapeutics?[J]. Mol Cancer Ther, 2010, 9(2): 268-278.
|
[8] |
Grgün G, Calabrese E, Hideshima T, et al. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma[J]. Blood, 2010, 115(25): 5202-5213.
|
[9] |
Gong Y, Li Y, Lu Y, et al. Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice[J]. Int J Cancer, 2011, 129(5): 1042-1052.
|
[10] |
赵正,吴丽君.黄芪提取物对大鼠氧自由基的影响[J].长治医学院学报,2012, 26(2):87-90.
|
[11] |
Zhao Z, Wu LJ. Astragalus extract to rat Oxygen free radical influence[J]. J Changzhi Med Coll, 2012, 26(2): 87-90.
|
[12] |
黄云峰,李连锟,谢早红,等. 黄芪注射液对H22荷瘤小鼠抗肿瘤作用机制[J]. 武警医学, 2011, 22(7) : 562-564.
|
[13] |
Huang YF, Li LK, Xie HH, et al. An experimental study on anti-tumor effects of Astragalus injection on H22 cell-bearing mice[J]. J Chin People’s Armed Police Forces, 2011,22(7):526-564.
|
[14] |
张晓清, 卞卫和, 李琳, 等. 三黄抗氧化方抑制乳腺癌MCF-7细胞氧化应激与增殖的实验研究[J]. 医学研究杂志, 2013, 42(12): 64-67.
|
[15] |
Zhang XQ, Bian WH, Li L, et al.Experimental research of effects of anti-oxidative stress of breast cancer MCF-7 cells and the mechanism with traditional Chinese decoction of Sanhuangkang oxide[J]. J Med Res, 2013, 42(12): 64-67.
|
[16] |
Niu NK, Wang ZL, Pan ST, et al. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway[J]. Drug Des Devel Ther, 2015, 9: 1555-1584.
|
[17] |
Ding YH, Zhou ZW, Ha CF, et al. Alisertib, anAurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells[J]. Drug Des Devel Ther, 2015, 9: 425-464.
|
[18] |
Yuan CX, Zhou ZW, Yang YX, et al. Inhibition of mitoticAurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells[J]. Drug Des Devel Ther, 2015, 9: 487-508.
|
[19] |
Wang H, Li R, Li L, et al. LRD-22, a novel dual dithiocarbamatic acid ester, inhibitsAurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells[J]. Biochem Biophys Res Commun, 2015, 458(1): 201-207.
|
[20] |
Qi L, Zhang Y. Alisertib (MLN8237), a selective Aurora-A kinase inhibitor, induces apoptosis in human tongue squamous cell carcinoma cell both in vitro and in vivo[J]. Tumour Biol, 2015, 36(3): 1797-1802.
|
[21] |
Tentler JJ, Ionkina AA, Tan AC, et al. p53 family members regulate phenotypic response to Aurora kinase a inhibition in Triple-Negative breast cancer[J]. Mol Cancer Ther, 2015, 14(5): 1117-1129.
|
[22] |
Hirota T, Kunitoku N, Sasayama T, et al.Aurora-A and an interacting activator, the LIM protein ajuba, are required for mitotic commitment in human cells[J]. Cell, 2003, 114(5): 585-598.
|
[23] |
Ando Y, Yasuda S, Oceguera-Yanez F, et al. Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells[J]. Mol Biol Cell, 2007, 18(10): 3752-3763.
|
[24] |
Karthigeyan D, Prasad SB, Shandilya J, et al. Biology of Aurora a kinase: implications in cancer manifestation and therapy[J]. Med Res Rev, 2011, 31(5): 757-793.
|